2023 SCI Investor Symposium – Event Playback
Presentations and discussion panels from the 2023 SCI Investor Symposium are listed chronologically below.
Opening Remarks by Brian M. Culley
2023 SCI Investor Symposium Chair, Brian M. Culley, provides an introduction to the first ever Annual SCI Investor Symposium held on June 29, 2023.
Presenter’s Address by Marco Baptista, PhD of the Reeve Foundation
Chief Scientific Officer Marco Baptista, PhD, provides an introduction to the Christopher and Dana Reeve Foundation.
SCI Clinical Trial Landscape by Richard G. Fessler, MD, PhD
Richard G. Fessler, MD, PhD of RUSH University Medical Center provides an overview of the current spinal cord injury (SCI) clinical trial landscape.
Discussion Panel 1: Persons with Lived Experience
Jack Allen, CFA, Senior Research Analyst of Biotechnology at Baird Equity Research moderates a panel discussion on living with SCI featuring Jake Javier, M.S. and Jerod Nieder
CIRM Presentation – Lila Collins, PhD
Lila Collins, PhD, Senior Science Officer at the California Institute for Regenerative Medicine (CIRM), presents at the 2023 SCI Investor Symposium.
Discussion Panel 2: The Future of Spinal Cord Injury Clinical Trials
Joseph Pantginis, Ph.D., Managing Director, Research, H.C. Wainwright & Co. Inc., moderates a panel discussion on the future of spinal cord injury clinical trials (Endpoints, Epidemiology and Global Considerations) featuring talks by Mary Jane Mulcahey, Ph.D., OTR/L, CPPC, CLCP, FASIA, Professor, Department of Occupational Therapy, Thomas Jefferson University and Michael Fehlings, M.D., Ph.D., FRCSC, FACS, Professor of Neurosurgery, University of Toronto.
AbbVie Corporate Presentation
Presented by Kimberly Pfleeger, Ph.D., Senior Scientific Director, Neuroscience Development at AbbVie
Lineage Cell Therapeutics, Inc. Corporate Presentation
Presented by Brian M. Culley, Chief Executive Officer at Lineage Cell Therapeutics, Inc.
Mitsubishi Tanabe Corporate Presentation
Presented by Konstantin Zubovskiy, M.D., M.B.A., Senior Director, Clinical Development, Global Early Development Team Lead at Mitsubishi Tanabe Pharma Development America, Inc.
NervGen Pharma Corp. Corporate Presentation
Presented by Daniel Mikol, M.D. Ph.D., Chief Medical Officer at NervGen Pharma Corp.
ONWARD Medical N.V. Corporate Presentation
Presented by Aditi Roy, Vice President, Communications at ONWARD Medical N.V. and James Guest M.D., Ph.D., FACS, Professor of Neurological Surgery, University of Miami.
EG 427 Corporate Presentation
Presented by Cornelia Haag-Molkenteller, M.D., Ph.D., Chief Medical Officer at EG 427.
Spinal Cord Outcomes Partnership Endeavor (SCOPE) Presentation
Presented by Linda Jones, PT, PhD, Collaborating Investigator at SCOPE & Chair of the Research Committee of the American Spinal Injury Association (ASIA) and Jane Hsieh, M.Sc, Accelerated Translational Program, Executive Director at Wings for Life & SCOPE Co-Chair